adverse effects of group a strep untreated
Group B strep infection is the most common cause of sepsis and meningitis in the United States during a newborn's first week of life. Group B strep infection can also afflict nonpregnant adults with certain chronic medical conditions, such as diabetes, cardiovascular disease, obesity, and cancer. Glomerulonephritis following acute streptococcal infection carries a very good prognosis -- 95% of patients recover spontaneously within three to four weeks without long-term sequelae (effects). STSS has a case-fatality rate of 30%-60%. 1 Group B strep are bacteria found normally in the intestine, vagina, and rectal area in about 25% of all healthy women. 2  Group B strep infections can affect neonates and adults. 3  Most pregnant women who are colonized by the bacteria have no symptoms. 1 Group B strep infections can affect neonates and adults. 2  Most pregnant women who are colonized by the bacteria have no symptoms. 3  The infection can be spread to infants before or during delivery. 4  Signs and symptoms in babies may include fever, breathing problems, lethargy, and poor feeding. About 1.5% of people with rheumatic carditis die of the disease annually. Morbidity and mortality rates have demonstrated steady improvement, a decline which is likely attributable to careful disease surveillance and initiation of prompt aggressive therapy. INTRODUCTION. Pharyngitis due to infection with group A Streptococcus (GAS) is usually a self-limited condition, with symptoms lasting two to five days in untreated patients. This type of bacteria (not to be confused with group A strep which causes  strep throat ) is commonly found in the human body, and it usually does not cause any symptoms. Although the body will typically cure strep throat on its own, leaving this infection untreated can possibly cause dangerous complications. Strep throat is a mild illness caused by an infection with group A streptococcus bacteria. Tonsillopharyngitis and uncomplicated skin and soft-tissue infections caused by GAS have a good prognosis. Patients who are long-term carriers may develop multiple episodes of infection, but these individuals are unlikely to spread the organism to close contacts and are at very low risk for developing complications. When begun within 48 hours of illness, antimicrobial therapy reduced the duration and severity of symptoms by one to two days in double-blind studies and prevented the spread of infection to contacts [ 1-3 ]. (See Treatment and prevention of streptococcal tonsillopharyngitis .).
Pharyngitis